ArticleBreast cancer research : BCR2018

Cleavage of the extracellular domain of junctional adhesion molecule-A is associated with resistance to anti-HER2 therapies in breast cancer settings.

Astrid O Leech et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.